Global Flow Cytometry Market – Size, Outlook, Trends, and Forecast (2024 – 2032)

The Global Flow Cytometry market size was valued at USD 3.29 billion in 2018 and is expected to grow at a CAGR of 10.68% over the forecast period. Flow Cytometry is a type of technology that is used to analyze the physical and chemical characteristics of particles in a fluid as it passes through at least one laser. Cell components are fluorescently characterized and then excited by the laser to emit light at varying wavelengths. The flow Cytometry technology is widely used in various fields of academic and clinical research, and diagnosis of diseases such as cancer, haematological malignancies and HIV.

Global Flow Cytometry Market Share:

By Technology, Cell-based flow Cytometry dominated the overall market. By Product Type, Instrument segment dominated the market owing to greater penetration coupled with advantages such as accurate result, cost-effective nature, and user-friendliness. By Application, Research segment dominated owing to an increasing R&D pertaining to cancer and other infectious diseases. By End-use, Commercial organization segment held the largest revenue share owing to wide applications across various verticals.

Global Flow Cytometry Market Size:

North America dominated the overall Flow Cytometry market in 2018 due to the presence of supportive government reforms for the development of advanced technologies for molecular diagnostics. Moreover, availability of skilled professionals and higher awareness level are some of the factors predictable to boost the regional market growth.

Global Flow Cytometry Market Growth:

Rising demand for point-of-care testing in chronic diseases management is expected to fuel the demand for cytometry techniques. Rising implementation of microfluidic miniature flow cytometry in point-of-care diagnostics is the major factor augmenting the future growth. Increasing R&D initiatives by various key players for the development of multicolour assays and advanced reagents for analysis are anticipated to boost the usage rate. Advancement in technology for the purpose of enhanced accuracy, portability, and cost-effectiveness is expected to serve this market with cost-effective growth opportunities.

Global Flow Cytometry Market Industry Analysis:

The Global flow cytometry market is mainly segmented based on the type of product, technology, application and the end users. Based on the products it’s further segmented into Instruments, systems, kits, Instrument support reagent,  reagents, fluorospheres and software.  Based on technology it is segmented into the bead-based flow and cell-based cytometry. Based on an application it is segmented as the clinical application, life science research and development. Based on end users it is segmented as academia, biotechnology,  hospitals, pharmaceuticals and clinical research organizations.

Global Flow Cytometry Market Outlook:

The market is competitive in nature as companies are involved in continuous product development and partnership alliances to aid market penetration. Increasing number of outsourcing service providers are expected to increase industry conflicts in the near future. Industry players are gaining market penetration by setting up manufacturing plants in primary regions of developing countries.

Global Flow Cytometry Market Trends:

Luminex Corporation has received FDA clearance for the ARIES Group A Strep Assay, a moderate complexity, a sample to answer test for the direct detection of Streptococcus pyogenes from throat swab specimens using the ARIES System. Beckman Coulter expands the detection boundaries of cytoflex flow Cytometry platform.

Global Flow Cytometry Market Research report includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
• Expertise investment opportunities by an analyst to the individual and organization to have the better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• Beckman Coulter
• Thermo Fisher Scientific, Inc.
• Luminex Corporation
• Bio-Rad Laboratories
• Sony Biotechnology Inc.